topotecan has been researched along with Lung Diseases, Interstitial in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Enomoto, Y; Hasegawa, H; Imokawa, S; Inui, N; Karayama, M; Matsui, T; Ozawa, Y; Suda, T; Yokomura, K | 1 |
| Fujimoto, D; Ito, J; Katakami, N; Kato, R; Kogo, M; Nagata, K; Nakagawa, A; Otoshi, T; Otsuka, K; Sato, Y; Shimizu, R; Teraoka, S; Tomii, K | 1 |
| Higashiguchi, M; Hirashima, T; Kawase, I; Kobayashi, M; Matsuura, Y; Morishita, N; Okamoto, N; Sasada, S; Suzuki, H; Tamiya, M; Tsumori, T; Uehara, N | 1 |
3 other study(ies) available for topotecan and Lung Diseases, Interstitial
| Article | Year |
|---|---|
Safety of topotecan monotherapy for relapsed small cell lung cancer patients with pre-existing interstitial lung disease.
Topics: Aged; Aged, 80 and over; Female; Humans; Lung Diseases, Interstitial; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Small Cell Lung Carcinoma; Topoisomerase I Inhibitors; Topotecan | 2015 |
Second-line Chemotherapy for Patients with Small Cell Lung Cancer and Interstitial Lung Disease.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Follow-Up Studies; Humans; Lung Diseases, Interstitial; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Prognosis; Retrospective Studies; Salvage Therapy; Small Cell Lung Carcinoma; Survival Rate; Topotecan | 2015 |
Effect of topotecan as second-line chemotherapy for small cell lung cancer patients with interstitial lung disease.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Lung Diseases, Interstitial; Lung Neoplasms; Male; Middle Aged; Retrospective Studies; Small Cell Lung Carcinoma; Topotecan | 2011 |